These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

872 related items for PubMed ID: 9551989

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
    Evans R, Kamdar SJ, Duffy TM, Krupke DM, Fuller JA, Dudley ME.
    Anticancer Res; 1995; 15(2):441-7. PubMed ID: 7763019
    [Abstract] [Full Text] [Related]

  • 3. Differential in situ expansion and gene expression of CD4+ and CD8+ tumor-infiltrating lymphocytes following adoptive immunotherapy in a murine tumor model system.
    Evans R, Duffy TM, Kamdar SJ.
    Eur J Immunol; 1991 Aug; 21(8):1815-9. PubMed ID: 1907916
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes.
    Evans R, Kamdar SJ, Duffy T, Edison L.
    J Immunol; 1993 Jan 01; 150(1):177-84. PubMed ID: 8417123
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation.
    Schwartzentruber DJ, Topalian SL, Mancini M, Rosenberg SA.
    J Immunol; 1991 May 15; 146(10):3674-81. PubMed ID: 1902860
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.
    Clin Immunol; 2009 Nov 15; 133(2):184-97. PubMed ID: 19664962
    [Abstract] [Full Text] [Related]

  • 12. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS, Ip G, Wright MA, Young MR.
    Cancer Res; 1995 Feb 15; 55(4):885-90. PubMed ID: 7850804
    [Abstract] [Full Text] [Related]

  • 13. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E, Aruga A, Arca MJ, Lee WM, Yang NS, Smith JW, Chang AE.
    Cancer Gene Ther; 1997 Feb 15; 4(3):157-66. PubMed ID: 9171934
    [Abstract] [Full Text] [Related]

  • 14. Tumor-specific cytokine release by donor T cells induces an effective host anti-tumor response through recruitment of host naive antigen presenting cells.
    Nagoshi M, Sadanaga N, Joo HG, Goedegebuure PS, Eberlein TJ.
    Int J Cancer; 1999 Jan 18; 80(2):308-14. PubMed ID: 9935215
    [Abstract] [Full Text] [Related]

  • 15. 1 alpha,25-dihydroxyvitamin D3 plus gamma-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells.
    Young MR, Halpin J, Wang J, Wright MA, Matthews J, Pak AS.
    Cancer Res; 1993 Dec 15; 53(24):6006-10. PubMed ID: 8261414
    [Abstract] [Full Text] [Related]

  • 16. Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role.
    Aruga A, Aruga E, Tanigawa K, Bishop DK, Sondak VK, Chang AE.
    J Immunol; 1997 Jul 15; 159(2):664-73. PubMed ID: 9218581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC, Conway TF, Sabel MS, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK.
    Cancer Res; 2002 Dec 15; 62(24):7254-63. PubMed ID: 12499267
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K.
    Clin Cancer Res; 2006 Nov 15; 12(22):6808-16. PubMed ID: 17121902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.